Patent Yatsopano ya US Yozindikira PTSD mu Nkhani Zamoyo

Written by mkonzi

Neurovation Labs, Inc., kampani yopanga sayansi yazachilengedwe yomwe ikuyang'ana ma biomarkers a PTSD kuti adziwe bwino komanso kulandira chithandizo, lero alengeza kuti US Patent and Trademark Office idapereka Patent ya US No. 11,224,668, pa Januware 18, 2022.

Sangalalani, PDF ndi Imelo

Patent, yotchedwa "Zolemba ndi Njira Zodziwira GluA1 mu Ubongo ndi Kuzindikiritsa Kukhalapo kwa GluA1-Mediated PTSD," imaperekedwa ku zolemba zamakono ndi njira zodziwira PTSD komanso kuchiza PTSD pambuyo pozindikira matendawa.              

"Zomwe zimatetezedwa ndi chilolezochi zikuchokera m'gulu lamagulu angapo omwe Neurovation Labs akupanga kuti athe kuzindikira zolinga za PTSD ndikuwunika bwino njira zomwe zimayambitsa PTSD ndi matenda ena amisala. Mankhwalawa ndi njira zofananira zomwe zimaperekedwa ndi patent zimayimira buku, njira yolunjika ku thanzi laubongo ndikuwona zovuta zokhudzana ndi ubongo," adatero Dr. Jennifer Perusini, Co-Founder & Chief Executive Officer wa kampaniyo.

Patent iyi ndi ya Neurovation Labs yokha ndipo ndiyoyamba kutulutsidwa kuchokera kuzinthu zambiri zaluso zochokera ku kafukufuku ndi chitukuko cha kampani.

Sangalalani, PDF ndi Imelo

Ponena za wolemba

mkonzi

Mkonzi wamkulu wa eTurboNew ndi Linda Hohnholz. Amakhala ku eTN HQ ku Honolulu, Hawaii.

Siyani Comment

eTurboNews | | Mbiri ya TravelIndustry